- How the ABVM-ENDO Scaled Score Actually Works
- What 555 Really Means on a 300-700 Scale
- Question Count, Timing, and Format
- Domain Weighting and Why It Drives Your Score
- What the 2025 Pass Rate Data Tells Candidates
- Registration and Fee Mechanics That Affect Your Attempt
- Scaled Score vs. Raw Score: Common Misreadings
- Where to Put Your Study Hours
- Frequently Asked Questions
- You need a scaled score of 555 out of a 300-700 range to pass the ABVM-ENDO exam.
- The exam has approximately 135 multiple-choice questions with two hours allotted.
- Treatment and Interventions is worth 64% of the exam - by far the largest domain.
- 2025 official data: 75% first-time pass rate, 100% repeat-candidate rate, 77% overall.
How the ABVM-ENDO Scaled Score Actually Works
Candidates preparing for the ABVM Endovascular Medicine Examination (ABVM-ENDO) almost always ask the same first question: "What score do I actually need?" The answer is straightforward on paper - a scaled score of 555 is required to pass, and scores are reported on a 300-700 range. What trips people up is understanding that this scaled score is not the same as a percentage of questions answered correctly. It's a converted score that accounts for the relative difficulty of the specific question set a candidate receives.
Because ABVM-ENDO is administered through APCA/Inteleos with Pearson VUE delivering the exam at test centers, the scoring process follows a standard psychometric conversion. That means two candidates who answer a different number of raw questions correctly could still land on either side of 555, depending on which items they saw and how those items are weighted. This is why generic "aim for 70%" advice circulating online doesn't map cleanly onto ABVM-ENDO - there is no published raw-score-to-pass conversion, and candidates should not assume one exists.
What 555 Really Means on a 300-700 Scale
Look at the numbers themselves: 555 sits well above the midpoint of a 300-700 range (which would be 500), but it isn't near the ceiling either. In practical terms, this tells candidates that ABVM-ENDO is calibrated to require solid, above-average command of the material - not perfection, and not a bare minimum squeak-through. You don't need to answer every question correctly, but you do need consistent performance across all four content domains, because a scaled score reflects overall demonstrated competence rather than strength in one area compensating for major gaps in another.
This is a critical distinction for anyone coming from a background heavy in one clinical area - say, diagnostic imaging - but lighter in procedural/interventional exposure. A candidate who is excellent in Domain 2 (Diagnosis and Testing) but weak in Domain 3 (Treatment and Interventions) will struggle to reach 555, simply because Treatment and Interventions represents such a disproportionate share of the exam content.
Key Takeaway
Treat 555 as a floor built on broad competence, not a target you can reach by over-indexing on your strongest domain. Balanced preparation across all four content areas is the only reliable path to the passing score.
Question Count, Timing, and Format
The ABVM-ENDO exam contains approximately 135 multiple-choice questions, and candidates are given two hours to complete the exam. Doing the math, that's roughly 53 seconds per question on average - a pace that rewards decisiveness and penalizes over-deliberation on any single item.
- Format: Multiple-choice, delivered at Pearson VUE test centers.
- Volume: ~135 items total across all four domains.
- Time budget: 120 minutes, meaning pacing discipline matters as much as content knowledge.
Because the question count is fixed and the time is fixed, your ability to hit 555 depends heavily on efficient recall - not looking things up mentally through slow first-principles reasoning during the exam itself. That efficiency has to be built well before test day. For a breakdown of how question style tends to present clinical scenarios versus straight recall, the ABVM-ENDO Study Guide walks through preparation sequencing in more detail.
Domain Weighting and Why It Drives Your Score
The single most important structural fact about the ABVM-ENDO exam - more important than any generic test-taking tip - is how unevenly the four domains are weighted. The current content outline (Version 24.1, tied to the 2026 exam cycle) breaks down as follows:
| Domain | Weight | Approx. Questions (of ~135) |
|---|---|---|
| Domain 1: Pathophysiology, Risk Factors, and Screening | 8% | ~11 |
| Domain 2: Diagnosis and Testing | 16% | ~22 |
| Domain 3: Treatment and Interventions | 64% | ~86 |
| Domain 4: Prognosis, Surveillance, and Re-intervention | 12% | ~16 |
Notice that Domain 3 alone accounts for nearly two-thirds of the entire exam. This isn't a minor emphasis - it's the exam. A candidate who masters Domains 1, 2, and 4 completely but only has moderate command of Treatment and Interventions will still likely fall short of 555, because that single domain carries more weight than the other three combined.
Domain 3: Treatment and Interventions (64%)
This domain covers the endovascular and open procedural decision-making that defines day-to-day practice for board-certified vascular medicine specialists sitting this exam.
- Procedural selection for peripheral arterial and venous disease
- Endovascular intervention indications, techniques, and complication management
- Post-procedural management and device/technique selection tradeoffs
- Integration of diagnostic findings into a treatment pathway
For a full breakdown of what each domain tests and how to sequence your review around this weighting, see the ABVM-ENDO Exam Domains Guide. If you're still calibrating how difficult the exam is relative to your current clinical exposure, How Hard Is the ABVM-ENDO Exam? addresses that question directly.
What the 2025 Pass Rate Data Tells Candidates
Official 2025 performance data shows a 75% first-time pass rate, a 100% repeat-candidate pass rate, and a 77% overall pass rate. These numbers are worth sitting with for a moment, because they tell a specific story: most candidates who prepare adequately clear 555 on their first attempt, and candidates who don't clear it the first time and return for a second attempt appear to pass at a very high rate.
That pattern suggests the exam isn't designed as a filter that repeatedly weeds out the same candidates - it's more consistent with a knowledge-gap problem that gets corrected once identified. In other words, a first-attempt miss is usually a signal about which domain (almost certainly Domain 3, given its weight) needs more attention, not a signal that the credential is out of reach.
For a deeper statistical breakdown, including how these figures compare across candidate types, the ABVM-ENDO Pass Rate article covers the full 2025 performance summary.
Registration and Fee Mechanics That Affect Your Attempt
Understanding the passing score in isolation isn't enough - you also need to understand what a failed attempt costs, because that shapes how seriously you should treat first-attempt preparation. The ABVM-ENDO exam fee is $1,370, which includes a $200 nonrefundable processing component. Candidates testing outside the United States, Canada, or Mexico pay an additional $50.
- Total standard fee: $1,370 (includes $200 nonrefundable processing)
- International testing surcharge: +$50 outside U.S./Canada/Mexico
- Application window for 2026: July 7 - September 15, 2026
- Testing window for 2026: September 29 - October 29, 2026
Because $200 of the fee is nonrefundable regardless of outcome, and because a repeat attempt means paying the fee structure again, there's a real financial incentive to treat your first sitting as the one you intend to pass - not a diagnostic run. A detailed cost breakdown, including how the fee compares across pathways, is available in the ABVM-ENDO Certification Cost guide, and the full 2026 registration and testing calendar is laid out in the ABVM-ENDO Exam Dates article.
Key Takeaway
With a $200 nonrefundable component built into every attempt, and a tight 2026 application window (July 7-September 15), plan your study timeline backward from the September 29-October 29 testing window rather than registering and cramming reactively.
Scaled Score vs. Raw Score: Common Misreadings
A frequent source of confusion is assuming the scaled score maps linearly to raw correct-answer percentage - for example, assuming 555 out of a 300-700 range translates neatly to roughly 65% of raw questions correct. This kind of arithmetic shortcut isn't supported by any published Inteleos documentation for ABVM-ENDO, and candidates should avoid building a study plan around a guessed conversion.
What you can say with confidence, based on the official structure:
- 555 is above the scale midpoint (500), indicating the passing bar reflects solid, not minimal, competence.
- The scaled score accounts for item difficulty, so raw percentage alone is an unreliable self-assessment tool during practice.
- Performance across all four domains factors into your final scaled result - there's no domain you can afford to entirely skip, even Domain 1 at 8%.
Rather than obsessing over converting practice-test percentages into a projected scaled score, use practice performance as a relative signal: are you improving domain by domain, and are you consistently strong in Domain 3 specifically? That's a more actionable measure than chasing a precise numeric prediction.
Where to Put Your Study Hours
Given the domain weighting and the mechanics of the scaled score, your preparation time should not be split evenly across four domains - it should roughly mirror the exam's own emphasis. A simple, defensible allocation looks like this:
Foundation: Domains 1 and 2
- Review pathophysiology, risk factors, and screening criteria (Domain 1)
- Build diagnostic and testing fluency (Domain 2) before layering on procedural decision-making
Core Emphasis: Domain 3
- Dedicate the majority of study time to Treatment and Interventions given its 64% weight
- Work through procedural indications, device selection, and complication scenarios repeatedly
Closing the Loop: Domain 4
- Cover prognosis, surveillance, and re-intervention criteria
- Connect Domain 4 content back to Domain 3 treatment decisions
Full-Scale Practice
- Run timed, mixed-domain practice sets weighted like the real exam
- Use a resource like our ABVM-ENDO practice test platform to simulate the 135-question, two-hour format under real time pressure
This weighting-aware sequencing is the single biggest lever you have, and it's far more specific - and more useful - than generic study-technique advice. If you want a condensed reference for last-week review, the ABVM-ENDO Cheat Sheet consolidates must-know facts across all four domains in one page. And if you haven't yet confirmed you meet eligibility requirements before investing in a study plan, check the ABVM-ENDO Requirements guide first - there's no point optimizing for a passing score before confirming your pathway qualifies you to sit the exam at all.
Frequently Asked Questions
You need a scaled score of 555 on a 300-700 range. This is not a raw percentage of correct answers; it's a converted score based on item difficulty and overall performance across all four content domains.
No single domain guarantees a pass on its own, but because Domain 3 (Treatment and Interventions) makes up 64% of the exam, strong performance there is essentially a prerequisite for reaching 555. Weakness in the other domains can still pull your scaled score down.
You would need to register and pay the exam fee again to retake it, which includes the $200 nonrefundable processing component each time. Official 2025 data shows a 100% pass rate for repeat candidates, suggesting most who reattempt after identifying their gaps do pass.
The exam contains approximately 135 multiple-choice questions with two hours allotted, which works out to under a minute per question on average.
The 555 scaled-score requirement on the 300-700 range is the published passing standard tied to the current content outline (Version 24.1) governing the 2026 exam cycle, with applications running July 7-September 15, 2026 and testing running September 29-October 29, 2026.